BDKRB2 and hereditary angioedema: Background: PHA121 is a bradykinin B2 receptor antagonist under development for treatment (PHVS416 softgel capsule formulation) and prevention (PHVS719 extended-release tablet) of Hereditary Angioedema (HAE) attacks.